| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 06/11/2009 | US20090149405 Virus-like particle containing a Dengue virus recombinant replicon |
| 06/11/2009 | US20090149393 Novel Proteins Within The Type E Botulinum Neurotoxin Complex |
| 06/11/2009 | US20090149391 Novel antimicrobial bolisin peptides |
| 06/11/2009 | US20090149387 Use of GLP-1 Peptides |
| 06/11/2009 | US20090149380 Vasostatin as marrow protectant |
| 06/11/2009 | US20090149378 Glp-1 analogues |
| 06/11/2009 | US20090149374 Neuropeptides |
| 06/11/2009 | US20090149372 bone morphogenic proteins; transforming growth factors; fusion proteins; drug screening; cardiovascular disorders |
| 06/11/2009 | US20090149339 Methods of Identifying Modulators of Interaction Between PDZ Domain Proteins and PL Proteins |
| 06/11/2009 | US20090149338 System for detecting protein-protein interactions |
| 06/11/2009 | US20090149331 Methods and compositions for polypeptide engineering |
| 06/11/2009 | US20090148948 Nucleic acids encoding a g-protein coupled receptor involved in taste transduction |
| 06/11/2009 | US20090148940 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148939 Novel fluorescent proteins from aequorea coerulscens and methods for using same |
| 06/11/2009 | US20090148936 Lentiviral vector-mediated gene transfer and uses thereof |
| 06/11/2009 | US20090148925 Single chain class I major histocompatibility complexes |
| 06/11/2009 | US20090148922 Pancreatic Cancer Genes |
| 06/11/2009 | US20090148921 Compositions and methods for enhancing apoptosis |
| 06/11/2009 | US20090148916 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR |
| 06/11/2009 | US20090148900 Hemcm42 nucleic acids |
| 06/11/2009 | US20090148890 Nucleic acid and amino acid sequences relating to streptococcus pneumoniae for diagnostics and therapeutics |
| 06/11/2009 | US20090148888 Recombinant toxin fragments |
| 06/11/2009 | US20090148872 Lipoprotein sensor |
| 06/11/2009 | US20090148868 Jab1 as a prognostic marker and a therapeutic target for human cancer |
| 06/11/2009 | US20090148867 Universal fluorescent sensors |
| 06/11/2009 | US20090148855 Nucleic acid encoding or targeting sodium channel scn3a alpha subunits |
| 06/11/2009 | US20090148854 Can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 184P1E2 can be used in active or passive immunization |
| 06/11/2009 | US20090148848 PITX2 Polynucleotide, Polypeptide and Methods of Use Therefor |
| 06/11/2009 | US20090148834 Methods of use of alpha-methylacyl-CoA racemase in hormone refractory and metastatic prostate cancers |
| 06/11/2009 | US20090148831 NS5A nucleotide sequence variation as a marker for interferon response |
| 06/11/2009 | US20090148601 Nanoloom for controlling polymer assembly |
| 06/11/2009 | US20090148555 Dihydroxy-Acid Dehydratase Gene and Use Thereof |
| 06/11/2009 | US20090148507 Chimeric polypeptides containing chemokine domains |
| 06/11/2009 | US20090148475 Glycoprotein 5 (GP5) and M protein of PRRSV linked by a disulfide bond gives rise to protective antigenic determinant (PAD polypeptide) that is used provide protection PRRSV; immunizing pigs |
| 06/11/2009 | US20090148471 Molecular Vaccine Linking an Endoplasmic Reticulum Chaperone Polypeptide to an Antigen |
| 06/11/2009 | US20090148469 Multicomponent meningococcal vaccine |
| 06/11/2009 | US20090148468 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides |
| 06/11/2009 | US20090148466 Process for the Preparation of Hypoallergenic Mosaic Antigens |
| 06/11/2009 | US20090148465 Mutants of the p4 protein of nontypable haemophilus influenzae with reduced enzymatic activity |
| 06/11/2009 | US20090148457 Hepatocyte growth factor receptor antagonists and uses thereof |
| 06/11/2009 | US20090148456 Canine rankl and methods for preparing and using the same |
| 06/11/2009 | US20090148454 Peptide Domain Required For Interaction Between The Envelope of a Virus Pertaining to The Herv-W Interference Group and an Hasct Receptor |
| 06/11/2009 | US20090148453 Monoclonal antibodies against HMGB1 |
| 06/11/2009 | US20090148451 Therapeutic anti-cytomegalovirus compounds |
| 06/11/2009 | US20090148448 Methods and compositions for modulating and detecting wisp activity |
| 06/11/2009 | US20090148441 Anti-Cancer Antibodies With Reduced Complement Fixation |
| 06/11/2009 | US20090148438 Binding Moieties Based on Shark Ignar Domains |
| 06/11/2009 | US20090148427 Platelet glycoprotein ib alpha fusion polypeptides and methods of use thereof |
| 06/11/2009 | US20090148408 Lactobacilli expressing biologically active polypeptides and uses thereof |
| 06/11/2009 | US20090148403 Interleukin-9 Antagonist Muteins and Their Pharmacological Methods of Use |
| 06/11/2009 | CA2853475A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708322A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708321A1 Genes that increase plant oil and method for using the same |
| 06/11/2009 | CA2708037A1 Mutant proteins and methods for producing them |
| 06/11/2009 | CA2707944A1 Methods for generating marker free transgenic plants |
| 06/11/2009 | CA2706258A1 Simian subfamily e adenoviruses sadv-39, -25.2, -26, -30, -37, and -38 and uses thereof |
| 06/11/2009 | CA2704518A1 Engineering enzymatically susceptible proteins |
| 06/11/2009 | CA2702940A1 New non-selective somatostatin analogues |
| 06/10/2009 | EP2068147A1 Method of isolation and self-assembly of small protein particles from blood and other biological materials |
| 06/10/2009 | EP2067863A2 Methods and compositions for diseases associated with amyloidosis |
| 06/10/2009 | EP2067862A1 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 06/10/2009 | EP2067858A1 Animal models for neurodegenerative diseases |
| 06/10/2009 | EP2067854A1 Improved bacterial host cell for the direct expression of peptides |
| 06/10/2009 | EP2067790A2 Agonist antibody against protein tyrosine kinase SAL-S1 |
| 06/10/2009 | EP2067787A1 Method for controlling insect populations |
| 06/10/2009 | EP2067786A1 Novel non selective analogs of somatostatin |
| 06/10/2009 | EP2067783A1 Genetically engineered P30 antigen, improved antigen cocktail, and uses thereof |
| 06/10/2009 | EP2067488A1 Albumin fusion proteins |
| 06/10/2009 | EP2067483A1 Analogues of GLP-1 |
| 06/10/2009 | EP2067045A1 A method of diagnosis and kit therefor |
| 06/10/2009 | EP2066697A2 Modified self-assembling peptides |
| 06/10/2009 | EP2066693A2 Modulating regulatory t cell activity via interleukin 35 |
| 06/10/2009 | EP2066692A1 Means and methods for the production of amyloid oligomers |
| 06/10/2009 | EP2066691A1 Use of natural, recombinant and synthetic resilins in cosmetics |
| 06/10/2009 | EP2066690A2 Membrane-anchored 2 microglobulin covalently linked to mhc class i peptide epitopes |
| 06/10/2009 | EP2066679A1 Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof |
| 06/10/2009 | EP2066419A1 Chromatography ligand comprising domain c from staphyloccocus aureus protein a for antibody isolation |
| 06/10/2009 | EP2066347A1 Interleukin-1 muteins linked to virus-like particles to treat il-1 associated diseases |
| 06/10/2009 | EP2066334A1 Rnai methods and compositions for stimulating proliferation of cells with adherent junctions |
| 06/10/2009 | EP1954716A4 Compositions and methods of modulating the taste and smell receptors and screening methods therefore |
| 06/10/2009 | EP1362109B1 Recombinant oligomeric protein complexes with enhanced immunogenic potential |
| 06/10/2009 | EP1352070B1 A fibrin/fibrinogen-binding conjugate |
| 06/10/2009 | EP1141004B1 Proteins from rana pipiens and their use in the treatment of tumors |
| 06/10/2009 | EP1062366B1 Detection of neoplasia by analysis of saliva |
| 06/10/2009 | CN101454342A Composition and methods for treatment of congestive heart failure |
| 06/10/2009 | CN101454341A Use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation |
| 06/10/2009 | CN101450966A Polypeptide of antimicrobial agent and use |
| 06/10/2009 | CN101450965A Rice flower organ differentiation and growth control gene PS and use thereof |
| 06/10/2009 | CN101450964A Genetic engineering antibiotic peptides as well as preparation method and application thereof |
| 06/10/2009 | CN100497628C Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 06/10/2009 | CN100497624C WT1-interacting protein WTIP |
| 06/10/2009 | CN100497604C Viral variants with altered susceptibility to nucleoside analogs and uses thereof |
| 06/10/2009 | CN100497393C Method of detecting precursor with a monoclonal antibody binding to the amino acids 41-46 of brain natriuretic peptide |
| 06/10/2009 | CN100497387C Chimeric proteins for cell targeting and apoptosis induction and methods of using same |
| 06/10/2009 | CN100497386C Antibodies of non-functional P2X7 receptor and its uses |
| 06/10/2009 | CN100497385C Antibodies of non-functional P 2 Chi 7 receptor and its uses of diagnosis and treatment of cancers and other syndrome |
| 06/10/2009 | CN100497384C Novel gonadotropin-releasing hormone, precursor peptides thereof and genes encoding the same |
| 06/10/2009 | CN100497383C Human blood high density lipoprotein and its preparation method and use |
| 06/10/2009 | CN100497382C Antitumor effect of mutant bik |
| 06/10/2009 | CN100497381C Muc1 and C end active fragment mutants, their encoding gene and use thereof |